IRIS
TASSO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.701
AS - Asia 1.212
NA - Nord America 915
SA - Sud America 100
AF - Africa 25
OC - Oceania 1
Totale 10.954
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.509
US - Stati Uniti d'America 849
SG - Singapore 498
CN - Cina 346
VN - Vietnam 199
FR - Francia 64
BD - Bangladesh 56
BR - Brasile 54
HK - Hong Kong 40
FI - Finlandia 36
DE - Germania 28
CA - Canada 25
AR - Argentina 22
JP - Giappone 18
MX - Messico 17
GB - Regno Unito 12
IQ - Iraq 10
ZA - Sudafrica 10
PK - Pakistan 8
CH - Svizzera 7
MA - Marocco 6
PH - Filippine 6
PY - Paraguay 6
RU - Federazione Russa 6
ID - Indonesia 5
IN - India 5
JM - Giamaica 5
PL - Polonia 5
CO - Colombia 4
EC - Ecuador 4
IE - Irlanda 4
SE - Svezia 4
TR - Turchia 4
CR - Costa Rica 3
NL - Olanda 3
SA - Arabia Saudita 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
BE - Belgio 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ES - Italia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
MD - Moldavia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
UA - Ucraina 1
VC - Saint Vincent e Grenadine 1
VG - Isole Vergini Britanniche 1
Totale 10.954
Salva come PNG Salva come JPEG
Città #
Genova 4.298
Genoa 2.704
Rapallo 737
Vado Ligure 620
San Jose 253
Singapore 253
Ashburn 91
Ho Chi Minh City 63
Lauterbourg 59
Council Bluffs 56
Beijing 52
Hanoi 46
New York 43
Hong Kong 37
Helsinki 34
Santa Clara 29
Bordighera 23
Frankfurt am Main 22
Milan 18
Tokyo 18
Tianjin 17
Los Angeles 15
Chicago 11
Florence 10
Da Nang 9
Mexico City 9
Buffalo 8
Phoenix 8
São Paulo 8
Biên Hòa 7
Boardman 7
Turin 7
Guangzhou 6
Padua 6
Zurich 6
Dallas 5
Des Moines 5
Haiphong 5
Hangzhou 5
London 5
North Bergen 5
Toronto 5
Warsaw 5
Baghdad 4
City of London 4
Dublin 4
Houston 4
Johannesburg 4
Kingston 4
Naples 4
Orem 4
Philadelphia 4
Phủ Lý 4
Rome 4
Amsterdam 3
Asunción 3
Bologna 3
Casablanca 3
Catania 3
Ljubljana 3
Long Xuyen 3
Modesto 3
Montevideo 3
Montreal 3
Ninh Bình 3
Phủ Từ Sơn 3
Queens 3
Rio de Janeiro 3
Wuppertal 3
Alajuela 2
Bari 2
Bear 2
Belgrade 2
Belo Horizonte 2
Birmingham 2
Borghetto di Vara 2
Boston 2
Brownsville 2
Brussels 2
Cagliari 2
Camerino 2
Cardiff 2
Cleveland 2
Clorinda 2
Columbus 2
Couva 2
Daleville 2
Davenport 2
Dhaka 2
Erbil 2
Greenville 2
Guayaquil 2
Hixson 2
Hải Dương 2
Iowa City 2
Istanbul 2
Jacksonville 2
José Bonifácio 2
Kapolei 2
Kenitra 2
Totale 9.781
Salva come PNG Salva come JPEG
Nome #
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 250
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives. 245
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools 243
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives 225
Benzimidazole derivatives endowed with potent antileishmanial activity 221
Acridine derivatives as anti-BVDV agents 215
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 213
Quinolizidinyl-benzimidazoles as platelet-antiaggregating agents 211
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells 205
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 193
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 190
Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities 190
Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules 189
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation 184
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines 183
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype 180
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide 180
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus 176
The Influence of the Nitrogen Substitution in Three Cytisine Derivatives as Ligands for the Neuronal nAChRs: A Structural and Theoretical Study 175
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation 174
Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents 172
Organometallic compounds in oncology: implications of novel organotins as antitumor agents 168
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation 165
Antitubercular and antiprotozoal activities of quinolizidinyl/pyrrolizidinylalkyliminophenazines 163
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 161
New coumarin hybrids with antiproliferative activity against a neuroblastoma cell line 160
N-Homolupinanoyl and N-(ω-lupinylthio)alkanoyl derivatives of some tricyclic systems as ligands for muscarinic M1 and M2 receptor subtypes 158
Celecoxib, a COX-2 inhibitor, blocks microglial activation induced by a neurotoxic conformer of hPrP90-231 157
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 157
Computational approaches for the design and chemical synthesis of novel F508del correctors in the treatment of cystic fibrosis 157
Epimerization of lupinine to epilupinine and vice versa. Reexamination of the structures of lupinal and epilupinal 155
New arylsparteine derivatives as positive inotropic drugs 155
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo 153
Synthesis and pharmacological evaluation of some thiolupinine derivatives 151
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction) 147
Synthesis, binding, and modeling studies of new cytisine derivatives as ligands for neuronal nicotinic acetylcholine receptor subtypes 143
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as potential potentiators of the chloride transport defect in cystic fibrosis 143
Short exposure to high concentrations of malondialdehyde does not mimic physiological conditions 142
Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors 141
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease 139
Cap 10 - Recettori adrenergici e farmaci attivi sulla neurotrasmissione adrenergica 138
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays 138
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays 137
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia 136
Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease 132
Cap 16 - Anestetici generali ed anestetici locali 131
Btk inhibitors: a medicinal chemistry and drug delivery perspective 130
Journey on naphthoquinone and anthraquinone derivatives: New insights in alzheimer’s disease 128
Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction 125
Synthesis and biological investigation of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)-benzimidazoles 114
Novel organotins as antitumor agents 114
Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors 114
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells 113
Cap 11 - Recettori della serotonina e farmaci attivi sulla neurotrasmissione serotoninergica 113
Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains 107
Cap. 9 - Farmaci attivi sulla neurotrasmissione colinergica 105
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives 104
Quinolizidinyl derivatives of bi- and tricyclic systems as AChE/BchE and beta-amyloid aggregation inhibitors, 102
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis 96
Microbiological Screening of 5-Functionalized Pyrazoles for the Future Development of Optimized Pyrazole-Based Delivery Systems 95
New pyrazolyl thioureas active against the Staphylococcus genus 92
Quinone-based derivatives: a new class of multi-target agents against Alzheimer’s disease 91
BMI-1 inhibition fights cancer chemoresistance by altering redox homeostasis and inducing lipid peroxidation 91
Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-([Formula: see text]-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines. 87
Glutathione in cancer progression and chemoresistance: an update 83
Synthesis and prelimary docking studies of new colchicine-benzotriazole hybrid compounds 82
Design and synthesis of new coumarin hybrids with antiproliferative activity against neuroblastoma cells 80
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells 79
Indole Antitumor Agents in Nanotechnology Formulations: An Overview 78
Further quinolizidine derivatives as antiarrhythmic agents-3 77
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells 76
Quinolizidine-derived lucanthone and amitriptyline analogues endowed with potent antileishmanial activity 76
The Development of FAK Inhibitors: A Five-Year Update 75
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 74
New naphtho- and anthraquinone derivatives as Cholinesterase inhibitors for the treatment of Alzheimer's disease 64
NEW HYBRID COUMARIN–SUBSTITUTED ALICYCLIC AMINES AS POTENTIAL MULTITARGET DIRECT LIGANDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 60
New insights on Fak and Fak inhibitors 57
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells 56
Hybrid molecules phenothiazine/cinnamic derivatives as MTDL and their biological evaluation 53
Nanotechnology for Pediatric Retinoblastoma Therapy 51
SYNTHESIS AND STRUCTURE–ACTIVITY RELATIONSHIP OF COUMARIN HYBRIDS WITH ANTIPROLIFERATIVE PROPERTIES AGAINST A MULTIDRUG-RESISTANT NEUROBLASTOMA CELL LINE 39
null 38
Nanotechnology of tyrosine kinase inhibitors in cancer therapy: A perspective 35
The Development of BTK Inhibitors: A Five-Year Update 31
New hybrids coumarins– substituted alicyclic amines as potential multi target direct ligands for the treatment of Alzheimer’s disease 30
null 28
Totale 11.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.330
article - articoli 31.125
book - libri 0
conference - conferenze 3.719
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.486
Totale 72.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022866 38 48 79 83 31 46 47 190 46 69 48 141
2022/2023860 74 55 15 91 155 151 4 57 140 5 101 12
2023/2024512 21 86 19 82 27 70 20 46 19 17 55 50
2024/20251.716 41 106 58 96 210 180 195 310 66 76 193 185
2025/20263.435 395 86 324 340 461 224 484 200 255 345 160 161
2026/2027220 220 0 0 0 0 0 0 0 0 0 0 0
Totale 11.184